Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty limited - methotrexate -

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

woolworths ltd - imiprothrin; cypermethrin - aerosol - imiprothrin ungrouped active 1.4 g/kg; cypermethrin pyrethroid active 2.0 g/kg - household insecticide - domestic surface spray - pest control - ant | bed bug | carpet beetle | clothes moth | cockroach | crawling insect | flea | millipede | silverfish | spider | ants | argentine ant | bedbug | cockroachs | ctenocephalides spp. | fleas | ground fleas | large cockroach | niditinea spp. | pharaoh ant | silverfish | small cockroach | tinea spp. | tineola spp.

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

bayer new zealand limited - bifonazole 1%{relative};   - shampoo - 1% w/w - active: bifonazole 1%{relative}   excipient: 2-bromo-2-(bromomethyl)pentanedinitrile, mixt. with 2-phenoxyethanol dexpanthenol dimeticone ethanol lactic acid lauril glucoside macrogol methyl glucose dioleate macrogols methyldibromo glutaronitrile oil, (perfume highlight d40838b ct) phytantriol purified water sodium hydroxide as sodium hydroxide solution 45%, for ph adjustment sodium laureth sulfate

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - potassium nitrate 5%{relative};  ; sodium fluoride 0.254%{relative} equivalent to 1149 ppm fluoride - toothpaste - active: potassium nitrate 5%{relative}   sodium fluoride 0.254%{relative} equivalent to 1149 ppm fluoride excipient: brilliant blue fcf carrageenan cocamidopropyl betaine colloidal silicon dioxide dental flavour tp 13863 glycerol hydrated silica isopentane macrogol 400 purified water saccharin sodium sodium hydroxide sodium methyl cocoyl taurate sorbitol sucralose xanthan gum

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - potassium nitrate 5%{relative};  ; sodium fluoride 0.254%{relative} equivalent to 1149 ppm fluoride - toothpaste - active: potassium nitrate 5%{relative}   sodium fluoride 0.254%{relative} equivalent to 1149 ppm fluoride excipient: brilliant blue fcf carrageenan cocamidopropyl betaine colloidal silicon dioxide glycerol hydrated silica isopentane macrogol 400 mint flavour tp 13219 purified water saccharin sodium sodium hydroxide sodium methyl cocoyl taurate sodium tripolyphosphate sorbitol sucralose xanthan gum

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

unilever australasia division of unilever new zealand limited - pyrithione zinc 0.98%{relative} - shampoo - 1% w/w - active: pyrithione zinc 0.98%{relative} excipient: 1,5-pentanediol carbomer citric acid cocamidopropyl betaine dimethiconol dimeticone ethylene glycol distearate glycerol glydant guar hydroxypropyltrimonium chloride sodium laureth sulfate / sodium c12-13 pareth sulfate lauromacrogol 1150 lauromacrogol 200 macrogols magnesium chloride magnesium nitrate methyl hydroxybenzoate methylchloroisothiazolinone and methylisothiazolinone milk, fat free peg-40 castor oil persea americana poloxamer 407 ppg-12-buteth-16 sodium benzoate sodium chloride sodium hydroxide sodium laureth sulfate sodium polynaphthalenesulfonate triethanolamine dodecylbenzenesulfonate trolamine sulfate water xanthan gum zinc sulfate

Egyesült Királyság - angol - DrWeigert

dr. weigert -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - methotrexate, quantity: 25 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - psoriasis therapy (see warning box): trexject may be of value in the symptomatic control of severe, recalcitrant, disabling psoriasis in adults which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.,rheumatoid arthritis therapy (see warning box): management of severe, recalcitrant, active rheumatoid arthritis in adults not responding to, or intolerant of, an adequate trial of nsaids and one or more disease modifying drugs. aspirin, nsaids and/or low dose steroids may be continued, although the possibility of increased toxicity with concomitant use of nsaids including salicylate has not been fully explored. steroids may be reduced gradually in patients who respond to methotrexate. combined use of methotrexate with gold or penicillamine, has not been studied and may increase the incidence of adverse effects. rest and physiotherapy as indicated should be continued.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - methotrexate, quantity: 22.5 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - psoriasis therapy (see warning box): trexject may be of value in the symptomatic control of severe, recalcitrant, disabling psoriasis in adults which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.,rheumatoid arthritis therapy (see warning box): management of severe, recalcitrant, active rheumatoid arthritis in adults not responding to, or intolerant of, an adequate trial of nsaids and one or more disease modifying drugs. aspirin, nsaids and/or low dose steroids may be continued, although the possibility of increased toxicity with concomitant use of nsaids including salicylate has not been fully explored. steroids may be reduced gradually in patients who respond to methotrexate. combined use of methotrexate with gold or penicillamine, has not been studied and may increase the incidence of adverse effects. rest and physiotherapy as indicated should be continued.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - methotrexate, quantity: 20 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - psoriasis therapy (see warning box): trexject may be of value in the symptomatic control of severe, recalcitrant, disabling psoriasis in adults which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.,rheumatoid arthritis therapy (see warning box): management of severe, recalcitrant, active rheumatoid arthritis in adults not responding to, or intolerant of, an adequate trial of nsaids and one or more disease modifying drugs. aspirin, nsaids and/or low dose steroids may be continued, although the possibility of increased toxicity with concomitant use of nsaids including salicylate has not been fully explored. steroids may be reduced gradually in patients who respond to methotrexate. combined use of methotrexate with gold or penicillamine, has not been studied and may increase the incidence of adverse effects. rest and physiotherapy as indicated should be continued.